Article info
PDFPaper
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis
- Correspondence to: Professor Oluf Andersen Institute of Clinical Neuroscience, Neurologen-Sahlgrenska, Sahlgrenska University Hospital, SE 413 45 Göteborg, Sweden; oluf.andersenneuro.gu.se
Citation
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis
Publication history
- Received January 12, 2003
- Accepted August 6, 2003
- Revised July 28, 2003
- First published April 16, 2004.
Online issue publication
April 16, 2004
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 Journal of Neurology Neurosurgery and Psychiatry